No black box warning on record for Opdualag
As of the latest FDA labeling reviewed, Opdualag (NIVOLUMAB AND RELATLIMAB-RMBW) does not carry a black box warning. Standard warnings and precautions still apply — see the full Opdualag medicine page for the complete safety profile.